Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$979K Sell
2,527
-543
-18% -$186K 0.07% 231
2026
Q1
$1.08M Buy
3,070
+463
+18% +$165K 0.08% 190
2025
Q4
$853K Sell
2,607
-414
-14% -$131K 0.06% 216
2025
Q3
$853K Sell
3,021
-25
-0.8% -$7.25K 0.07% 195
2025
Q2
$850K Buy
3,046
+1,433
+89% +$406K 0.07% 188
2025
Q1
$420K Hold
1,613
– – 0.04% 263
2024
Q4
$420K Buy
1,613
+923
+134% +$274K 0.05% 180
2024
Q3
$222K Sell
690
-2
-0.3% -$654 0.04% 253
2024
Q2
$233K Sell
692
-1,904
-73% -$559K 0.04% 238
2024
Q1
$739K Sell
2,596
-483
-16% -$141K 0.14% 100
2023
Q4
$887K Buy
3,079
+362
+13% +$98.6K 0.19% 85
2023
Q3
$730K Buy
2,717
+989
+57% +$247K 0.19% 74
2023
Q2
$418K Hold
1,728
– – 0.14% 80
2023
Q1
$418K Sell
1,728
-5
-0.3% -$1.23K 0.13% 96
2022
Q4
$457K Buy
+1,733
New +$465K 0.15% 81

Other funds holding AMGN

Ethos Financial Group's AMGN Position: Q2 2026 in Review

Ethos Financial Group reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $186K and leaving 2,527 shares worth $979K. The position accounts for 0.07% of the portfolio, ranked #231.

Ethos Financial Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.08M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ethos Financial Group held 2,527 shares of Amgen worth $979K as of Q2 2026.
  • Ethos Financial Group sold 543 Amgen shares in Q2 2026, an estimated $186K.
  • Amgen made up 0.07% of Ethos Financial Group's portfolio in Q2 2026, its #231 holding.
  • Ethos Financial Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Ethos Financial Group's Amgen position peaked at $1.08M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.